Baxter BioScience is undertaking a voluntary market withdrawal of its IV immune globulin product GammaGard Liquid. News item 18 January 2013 Pages: 4 - 4
Conversion to everolimus not associated with altered glucose metabolism Clinical study 18 January 2013 Pages: 4 - 4